http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0098161-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-587 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 |
| filingDate | 1983-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa10f0ccd7900f608d0c5abd0c4e59eb |
| publicationDate | 1984-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0098161-A2 |
| titleOfInvention | Cephalosporin compounds |
| abstract | Cephalosporin compounds of general formula(wherein R' represents a hydrogen atom or a carboxyl blocking group, R<sup>2</sup> represents an amino or protected amino group, X represents a halogen atom or a hydroxyl or acetoxy group, B is S or S - O, and the dotted line bridging the 2-, 3- and 4-positions indicates that the compound is a ceph-2-em or ceph-3-em compound) and salts thereof. The compounds may be useful in the preparation of other cephalosporin compounds possessing antibiotic activity. Futhermore, ceph-3-em compounds of formula (1) in which R<sup>2</sup> is an amino group, B is S and X is hydroxy or acetoxy, as well as the non-toxic salts and non-toxic metabolically labile esters thereof, themselves exhibit antibiotic activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0148004-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0148004-A2 |
| priorityDate | 1982-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 342.